Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee on Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH); Meeting, 59316-59317 [2020-20706]
Download as PDF
<![CDATA[
59316
Federal Register / Vol. 85, No. 183 / Monday, September 21, 2020 / Notices
Testing Course Approval Program. The
program consists of an application
submitted by potential sponsors
(universities, hospitals, and private
consulting firms) who seek NIOSH
approval to conduct courses, and if
approved, notification to NIOSH of any
course or faculty changes during the
approval period, which is limited to five
years. The application form and added
materials, including an agenda,
curriculum vitae, and course materials
are reviewed by NIOSH to determine if
the applicant has developed a program
which adheres to the criteria required in
the Standard. Following approval, any
subsequent changes to the course are
submitted by course sponsors via letter
or email and reviewed by NIOSH staff
to assure that the changes in faculty or
course content continue to meet course
requirements. Course sponsors also
voluntarily submit an annual report to
inform NIOSH of their class activity
level and any faculty changes.
Sponsors who elect to have their
approval renewed for an additional five
year period, submit a renewal
application and supporting
documentation for review by NIOSH
staff to ensure the course curriculum
meets all current standard requirements.
Approved courses that elect to offer
NIOSH-Approved Spirometry Refresher
Courses must submit a separate
application and supporting documents
for review by NIOSH staff. Institutions
and organizations throughout the
country voluntarily submit applications
and materials to become course
sponsors and carry out training.
Submissions are required for NIOSH to
evaluate a course and determine
whether it meets the criteria in the
Standard and whether technicians will
be adequately trained as mandated
under the Standard.
NIOSH will disseminate a one-time
customer satisfaction survey to course
directors and sponsor representatives to
evaluate our service to courses, the
effectiveness of the program changes
implemented since 2005, and the
usefulness of potential Program
enhancements.
Application form changes consist of
minor text edits that clarify questions
and information, thereby reducing the
need for applicants to contact NIOSH
for guidance. In addition, parts of the
forms were reformatted to reduce
redundancy and increase clarity for
applicants. Two of the forms have
updated titles which reflect the purpose
of the applications (initial sponsorship
and sponsorship renewal forms).
The estimated annual burden to
respondents is 147 hours. There will be
no cost to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Potential Sponsors ..........................................
Initial Application ............................................
Annual Report ................................................
Report for Course Changes ...........................
Renewal Application .......................................
Refresher Course Application ........................
One-Time Customer Satisfaction Survey ......
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–20759 Filed 9–18–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH),
Subcommittee on Dose
Reconstruction Reviews (SDRR),
National Institute for Occupational
Safety and Health (NIOSH); Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Dose
Reconstruction Reviews Subcommittee
SUMMARY:
VerDate Sep<11>2014
19:59 Sep 18, 2020
Jkt 250001
(SDRR) of the Advisory Board on
Radiation and Worker Health (ABRWH
or the Advisory Board). This meeting is
open to the public, but without a public
comment period. The public is welcome
to submit written comments in advance
of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
DATES: The meeting will be held on
November 4, 2020, from 10:30 a.m. to
4:00 p.m., EST. Written comments must
be received on or before October 28,
2020.
You may submit comments
by mail to: Sherri Diana, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
34, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
ADDRESSES:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
3
34
24
13
3
32
Number of
responses per
respondent
Average
burden per
response
(in hours)
1
1
1
1
1
1
3.5
28/60
30/60
6
8
12/60
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Toll Free 1(800)CDC–
INFO, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
E:\FR\FM\21SEN1.SGM
21SEN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 183 / Monday, September 21, 2020 / Notices
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
13889 on March 22, 2020, and will
terminate on March 22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Set 28, possibly
including cases involving, Oak Ridge
Gaseous Diffusion Plant (K25), Y–12
Plant, and Savannah River Site (SRS)
and potentially other Department of
Energy and Atomic Weapons Employers
facilities; Dose reconstruction cases
under review from Set 25, possibly
including cases involving, Hooker
Electrochemical, Nuclear Metals Inc.,
West Valley Demonstration Project,
Carborundum, Metals and Controls Corp
and potentially other Department of
Energy and Atomic Weapons Employers
facilities; and Dose reconstruction cases
under review from Set 27, possibly
including cases involving, Oak Ridge
Gaseous Diffusion Plant (K25), Paducah
Gaseous Diffusion Plant, SRS and
potentially other Department of Energy
and Atomic Weapons Employers
facilities.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
VerDate Sep<11>2014
19:59 Sep 18, 2020
Jkt 250001
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–20706 Filed 9–18–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0100]
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public. Time will be available for public
comment. The meeting will be webcast
live via the World Wide Web.
DATES: The meeting will be held on
October 28–29, 2020 from 10:00 a.m. to
5:30 p.m., EDT (times subject to
change).
Written comments must be received
on or before October 29, 2020.
ADDRESSES: For more information on
ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/
index.html.
You may submit comments, identified
by Docket No. CDC–2020–0100 by any
of the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2020–0100,
c/o Attn: October ACIP Meeting, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, MS H24–8,
Atlanta, GA 30329–4027.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
59317
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: Purpose:
The committee is charged with advising
the Director, CDC, on the use of
immunizing agents. In addition, under
42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters to be Considered: The agenda
will include discussions on COVID–19
vaccines, CDC immunization schedules,
seasonal influenza vaccines,
pneumococcal vaccines, orthopoxvirus
vaccine, dengue vaccine, recombinant
zoster vaccine, rabies vaccines, and
tickborne encephalitis vaccine. A
recommendation vote on the CDC
immunization schedules is scheduled.
Agenda items are subject to change as
priorities dictate. For more information
on the meeting agenda visit https://
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Comments received are part of the
public record and are subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
E:\FR\FM\21SEN1.SGM
21SEN1
]]>Agencies
[Federal Register Volume 85, Number 183 (Monday, September 21, 2020)]
[Notices]
[Pages 59316-59317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20706]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH),
Subcommittee on Dose Reconstruction Reviews (SDRR), National Institute
for Occupational Safety and Health (NIOSH); Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Subcommittee for Dose
Reconstruction Reviews Subcommittee (SDRR) of the Advisory Board on
Radiation and Worker Health (ABRWH or the Advisory Board). This meeting
is open to the public, but without a public comment period. The public
is welcome to submit written comments in advance of the meeting, to the
contact person below. Written comments received in advance of the
meeting will be included in the official record of the meeting. The
public is also welcomed to listen to the meeting by joining the audio
conference (information below). The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on November 4, 2020, from 10:30 a.m. to
4:00 p.m., EST. Written comments must be received on or before October
28, 2020.
ADDRESSES: You may submit comments by mail to: Sherri Diana, National
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS
C-34, Cincinnati, Ohio 45226.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone: (513) 533-6800, Toll Free 1(800)CDC-
INFO, Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
[[Page 59317]]
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and rechartered under Executive Order
13889 on March 22, 2020, and will terminate on March 22, 2022.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. SDRR was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Considered: The agenda will include discussions on
the following dose reconstruction program quality management and
assurance activities: Dose reconstruction cases under review from Set
28, possibly including cases involving, Oak Ridge Gaseous Diffusion
Plant (K25), Y-12 Plant, and Savannah River Site (SRS) and potentially
other Department of Energy and Atomic Weapons Employers facilities;
Dose reconstruction cases under review from Set 25, possibly including
cases involving, Hooker Electrochemical, Nuclear Metals Inc., West
Valley Demonstration Project, Carborundum, Metals and Controls Corp and
potentially other Department of Energy and Atomic Weapons Employers
facilities; and Dose reconstruction cases under review from Set 27,
possibly including cases involving, Oak Ridge Gaseous Diffusion Plant
(K25), Paducah Gaseous Diffusion Plant, SRS and potentially other
Department of Energy and Atomic Weapons Employers facilities.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-20706 Filed 9-18-20; 8:45 am]
BILLING CODE 4163-18-P
